|
Volumn 25, Issue 9, 2015, Pages 1836-1841
|
Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4
|
Author keywords
Drug discovery; Inflammation; Interleukin receptor associated kinases; SAR; Structure based drug design
|
Indexed keywords
2,6-DIAMINOPYRIMIDINE;
INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE;
PROTEIN KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
ANTAGONISTS AND INHIBITORS;
CHEMICAL STRUCTURE;
CHEMISTRY;
DOSE RESPONSE;
DRUG DEVELOPMENT;
HUMAN;
METABOLISM;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DISCOVERY;
HUMANS;
INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84934789081
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2015.03.043 Document Type: Article |
Times cited : (16)
|
References (20)
|